Can lessons from Immunity Community help build acceptance of COVID-19 vaccines? Clarissa Hsu, PhD, thinks so.
How Paula Blasi brings research findings to light to support Kaiser Permanente’s rapid response to COVID-19
Dr. Eric B. Larson, a report contributor, answers questions about reducing risks, disparities, and threats from COVID-19.
National Institute of Allergy and Infectious Diseases-sponsored phase 1 trial tested mRNA vaccine.
Dr. Mike Jackson has long studied the spread of flu and effectiveness of vaccination at Kaiser Permanente Washington. And now… of COVID-19 too.
Older people must guard against social isolation, as well as COVID-19, to stay well and thrive, writes Dr. Eric B. Larson.
Melissa Parson shares 4 lessons she learned while on assignment with Kaiser Permanente Washington diabetes nurses.
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.